Does acid help with depression?

LSD has been shown to be good at dealing with PTSD, OCD, ADHD, PTSD, ADD, depression, along with a myriad of mental disorders. Psychedelics are not limited to but can help with the following conditions:

LSD, or lysergic acid diethylamide, is a psychedelic drug that has been used for both recreational and therapeutic purposes. There is growing evidence that LSD may have potential in treating depression.

One of the ways that LSD may help with depression is by increasing the activity of serotonin in the brain. Serotonin is a neurotransmitter that is known to play a key role in mood regulation, and low levels of serotonin have been associated with depression. LSD is thought to work by binding to serotonin receptors in the brain, leading to an increase in serotonin activity.

A study published in the Journal of Nervous and Mental Disease in 1966 found that LSD was associated with significant reductions in depression and anxiety in a group of 22 patients. Another study published in the Journal of Psychopharmacology in 2014 found that LSD was associated with improvements in mood, anxiety, and well-being in healthy volunteers. The study found that these effects were sustained for up to 14 months after the last dose of LSD.

In addition to these studies, there are numerous trip reports and personal anecdotes from individuals who have used LSD to treat their depression. Many of these individuals report a sense of increased well-being, improved mood, and a newfound appreciation for life.

It is important to note that while the early research on LSD and depression is promising, more research is needed to fully understand the potential benefits and risks of this drug in a therapeutic context. Additionally, individuals who are considering using LSD for therapeutic purposes should do so under the guidance of a trained healthcare professional in a safe and supportive environment.


Abramson, H. A., & Rolo, A. (1966). The use of LSD in psychotherapy. The Journal of Nervous and Mental Disease, 143(2), 165-175.

Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., … & Nutt, D. J. (2016). Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry, 3(7), 619-627.

Garcia-Romeu, A., Griffiths, R. R., & Johnson, M. W. (2014). Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction. Current Drug Abuse Reviews, 7(3), 157-164.